<?xml version='1.0' encoding='utf-8'?>
<document id="10950847"><sentence text="Cytochrome P450 3A4-mediated interaction of diclofenac and quinidine."><entity charOffset="44-54" id="DDI-PubMed.10950847.s1.e0" text="diclofenac" /><entity charOffset="59-68" id="DDI-PubMed.10950847.s1.e1" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.10950847.s1.e0" e2="DDI-PubMed.10950847.s1.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s1.e0" e2="DDI-PubMed.10950847.s1.e1" /></sentence><sentence text="The metabolism of diclofenac to its 5-hydroxylated derivative in humans is catalyzed by cytochrome P450 (CYP)3A4"><entity charOffset="18-28" id="DDI-PubMed.10950847.s2.e0" text="diclofenac" /></sentence><sentence text=" We report herein that in vitro this biotransformation pathway is stimulated by quinidine"><entity charOffset="80-89" id="DDI-PubMed.10950847.s3.e0" text="quinidine" /></sentence><sentence text=" When diclofenac was incubated with human liver microsomes in the presence of quinidine, the formation of 5-hydroxydiclofenac increased approximately 6-fold relative to controls"><entity charOffset="6-16" id="DDI-PubMed.10950847.s4.e0" text="diclofenac" /><entity charOffset="78-87" id="DDI-PubMed.10950847.s4.e1" text="quinidine" /><entity charOffset="106-125" id="DDI-PubMed.10950847.s4.e2" text="5-hydroxydiclofenac" /><pair ddi="false" e1="DDI-PubMed.10950847.s4.e0" e2="DDI-PubMed.10950847.s4.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s4.e0" e2="DDI-PubMed.10950847.s4.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s4.e0" e2="DDI-PubMed.10950847.s4.e2" /><pair ddi="false" e1="DDI-PubMed.10950847.s4.e1" e2="DDI-PubMed.10950847.s4.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s4.e1" e2="DDI-PubMed.10950847.s4.e2" /></sentence><sentence text=" Similar phenomena were observed with diastereoisomers of quinidine, including quinine and the threo epimers, which produced an enhancement in the formation of 5-hydroxydiclofenac in the order of 6- to 9-fold"><entity charOffset="58-67" id="DDI-PubMed.10950847.s5.e0" text="quinidine" /><entity charOffset="79-86" id="DDI-PubMed.10950847.s5.e1" text="quinine" /><entity charOffset="160-179" id="DDI-PubMed.10950847.s5.e2" text="5-hydroxydiclofenac" /><pair ddi="false" e1="DDI-PubMed.10950847.s5.e0" e2="DDI-PubMed.10950847.s5.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s5.e0" e2="DDI-PubMed.10950847.s5.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s5.e0" e2="DDI-PubMed.10950847.s5.e2" /><pair ddi="false" e1="DDI-PubMed.10950847.s5.e1" e2="DDI-PubMed.10950847.s5.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s5.e1" e2="DDI-PubMed.10950847.s5.e2" /></sentence><sentence text=" This stimulation of diclofenac metabolism was diminished when human liver microsomes were pretreated with a monoclonal inhibitory antibody against CYP3A4"><entity charOffset="21-31" id="DDI-PubMed.10950847.s6.e0" text="diclofenac" /></sentence><sentence text=" In contrast, neither cytochrome b(5) nor CYP oxidoreductase appeared to mediate the stimulation of diclofenac metabolism by quinidine, suggesting that the effect of quinidine is mediated through CYP3A4 protein"><entity charOffset="100-110" id="DDI-PubMed.10950847.s7.e0" text="diclofenac" /><entity charOffset="125-134" id="DDI-PubMed.10950847.s7.e1" text="quinidine" /><entity charOffset="166-175" id="DDI-PubMed.10950847.s7.e2" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.10950847.s7.e0" e2="DDI-PubMed.10950847.s7.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s7.e0" e2="DDI-PubMed.10950847.s7.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s7.e0" e2="DDI-PubMed.10950847.s7.e2" /><pair ddi="false" e1="DDI-PubMed.10950847.s7.e1" e2="DDI-PubMed.10950847.s7.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s7.e1" e2="DDI-PubMed.10950847.s7.e2" /></sentence><sentence text=" Further kinetic analyses indicated that V(max) values for the conversion of diclofenac to its 5-hydroxy derivative increased 4"><entity charOffset="77-87" id="DDI-PubMed.10950847.s8.e0" text="diclofenac" /><entity charOffset="95-104" id="DDI-PubMed.10950847.s8.e1" text="5-hydroxy" /><pair ddi="false" e1="DDI-PubMed.10950847.s8.e0" e2="DDI-PubMed.10950847.s8.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s8.e0" e2="DDI-PubMed.10950847.s8.e1" /></sentence><sentence text="5-fold from 13" /><sentence text="2 to 57" /><sentence text="6 nmol/min/nmol of CYP with little change in K(m) (71-56 microM) over a quinidine concentration range of 0 to 30 microM"><entity charOffset="72-81" id="DDI-PubMed.10950847.s11.e0" text="quinidine" /></sentence><sentence text=" Conversely, the metabolism of quinidine was not affected by the presence of diclofenac; the K(m) value estimated for the formation of 3-hydroxyquinidine was approximately 1"><entity charOffset="31-40" id="DDI-PubMed.10950847.s12.e0" text="quinidine" /><entity charOffset="77-87" id="DDI-PubMed.10950847.s12.e1" text="diclofenac" /><entity charOffset="135-153" id="DDI-PubMed.10950847.s12.e2" text="3-hydroxyquinidine" /><pair ddi="false" e1="DDI-PubMed.10950847.s12.e0" e2="DDI-PubMed.10950847.s12.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s12.e0" e2="DDI-PubMed.10950847.s12.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s12.e0" e2="DDI-PubMed.10950847.s12.e2" /><pair ddi="false" e1="DDI-PubMed.10950847.s12.e1" e2="DDI-PubMed.10950847.s12.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s12.e1" e2="DDI-PubMed.10950847.s12.e2" /></sentence><sentence text="5 microM, similar to the quinidine concentration required to produce 50% of the maximum stimulatory effect on diclofenac metabolism"><entity charOffset="25-34" id="DDI-PubMed.10950847.s13.e0" text="quinidine" /><entity charOffset="110-120" id="DDI-PubMed.10950847.s13.e1" text="diclofenac" /><pair ddi="false" e1="DDI-PubMed.10950847.s13.e0" e2="DDI-PubMed.10950847.s13.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s13.e0" e2="DDI-PubMed.10950847.s13.e1" /></sentence><sentence text=" It appears that the enhancement of diclofenac metabolism does not interfere with quinidine's access to the ferriheme-oxygen complex, implicating the presence of both compounds in the active site of CYP3A4 at the same time"><entity charOffset="36-46" id="DDI-PubMed.10950847.s14.e0" text="diclofenac" /></sentence><sentence text=" Finally, a approximately 4-fold increase in 5-hydroxydiclofenac formation was observed in human hepatocyte suspensions containing diclofenac and quinidine, demonstrating that this type of drug-drug interaction occurs in intact cells"><entity charOffset="45-64" id="DDI-PubMed.10950847.s15.e0" text="5-hydroxydiclofenac" /><entity charOffset="131-141" id="DDI-PubMed.10950847.s15.e1" text="diclofenac" /><entity charOffset="146-155" id="DDI-PubMed.10950847.s15.e2" text="quinidine" /><pair ddi="false" e1="DDI-PubMed.10950847.s15.e0" e2="DDI-PubMed.10950847.s15.e0" /><pair ddi="false" e1="DDI-PubMed.10950847.s15.e0" e2="DDI-PubMed.10950847.s15.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s15.e0" e2="DDI-PubMed.10950847.s15.e2" /><pair ddi="false" e1="DDI-PubMed.10950847.s15.e1" e2="DDI-PubMed.10950847.s15.e1" /><pair ddi="false" e1="DDI-PubMed.10950847.s15.e1" e2="DDI-PubMed.10950847.s15.e2" /></sentence><sentence text="" /></document>